
Centrus signs HALEU supply deal with Antares
- Centrus Energy (NYSE:LEU) signed a multi-year agreement to supply HALEU to Antares Nuclear.
- Deliveries are scheduled to begin before the end of the decade, supporting advanced reactor projects.
- The agreement includes customer prepayments to help support expansion of domestic uranium enrichment capacity.
Centrus Energy (NYSE:LEU) signed a definitive multi-year contract to supply High-Assay Low-Enriched Uranium (HALEU) to Antares Nuclear, with deliveries scheduled to begin before the end of the decade.
The agreement adds another HALEU customer to Centrus Energy’s backlog and provides Antares with a U.S.-origin uranium supply source intended to support advanced reactor projects for space and national security applications.
The contract includes prepayments from Antares that will help fund the expansion of domestic enrichment capacity, while Centrus continues development of HALEU production capabilities at its American Centrifuge Plant.
Centrus Energy supplies nuclear fuel and services, including enriched uranium products for commercial and government customers, and is developing domestic HALEU production capabilities.
The company said its American Centrifuge Plant is the only licensed HALEU production facility in the western world and that its expansion plans include large-scale HALEU and low-enriched uranium production.
Frequently asked questions
More from United States
Amazon Q3 revenue accelerates 12% to $201.9 billion as AWS growth accelerates
Intel Q3 revenue skyrockets 21% to $16.5B as data center sales surge
Merck raises FY profit outlook as Q3 revenue climbs 5% to $18.1B
Eli Lilly Q3 revenue surges 39% to $24.4 billion as guidance rises
Enterprise Products Q3 EBITDA jumps 16% to $2.8 billion
KBR Q3 revenue rises 5% to $2 billion as adjusted EBITDA grows 12%
-1-640x359.webp&w=3840&q=75)